Navigating Wisconsin Medical Cannabis Laws

In 2014, Lydia’s Law (AB 726) was enacted, allowing patients with seizure disorders to access and possess CBD treatment with THC limited to 0.3% or less, but there is no patient registry, no licensed dispensary system, and no formal program infrastructure. The 2019 Wisconsin Act 68 later amended the law to expand eligibility beyond seizure disorders. Under current law, a pharmacy or physician-approved may dispense cannabidiol products as a treatment for a medical condition, and a licensed physician may issue an individual a certification stating that the individual possesses a cannabidiol product to treat a medical condition.
Senate Bill 534 (2025), which would have established a comprehensive regulated medical cannabis program in Wisconsin, was introduced in October 2025 and passed out of committee in February 2026. The bill did not receive a floor vote before the legislature adjourned and did not become law. As of the date of this publication, no comprehensive medical cannabis program legislation has been enacted in Wisconsin.
Although Wisconsin does not yet have a comprehensive medical cannabis program, advocates and patients are working to change that. Interested in advocating for medical cannabis patients' rights? Find out how you can work with Americans for Safe Access to support patients in your community and across the country.
|
0 Registered Patient Population |
0.00% of Total Population Represented by Patients |
0 Total Medical Retail Locations Currently in Operation |
N/A Patients : Retail |
*UPDATE: AG ORDER NO. 6754-2026 CHANGED FEDERAL CANNABIS LAWS ON APRIL 28, 2026. Learn more here. It is important to stay active, engaged, and informed. Sign up to get ASA updates.
Patients and their caregivers should be aware that their rights and legal protections* vary by state, age, and even the chemical composition of a product. Medical professionals have federal protections to discuss cannabis medicines with their patients, but incorporating them into their patients' treatment regimen is a very different process than writing a prescription. Laws and regulations are constantly evolving and require consistent advocacy to ensure better patient outcomes.
Americans for Safe Access has taken the guesswork out of navigating applicable laws, regulations, and available resources with these stakeholder resources.
*UPDATE: AG ORDER NO. 6754-2026 CHANGED FEDERAL CANNABIS LAWS ON APRIL 28, 2026: Learn more here.
Federal cannabis laws affect far more than whether a patient can access medical cannabis. For decades, federal prohibition has limited protections for medical cannabis patients under laws such as the Americans with Disabilities Act (ADA) and the Fair Housing Act (FHA). As a result, patients have often been denied the basic protections that people with other serious health conditions expect in employment, housing, healthcare, and access to federal programs.
Federal prohibition has also affected patients’ access to essential healthcare, housing, and financial support programs, sometimes forcing patients to choose between the medicine they need and the benefits they depend on. It has also created barriers to federal employment, healthcare autonomy, firearm ownership, and other aspects of daily life.
As federal and state cannabis laws change, implementation matters. Advocates must stay vigilant to ensure public agencies, private institutions, employers, housing providers, and healthcare systems update their policies in ways that respect patient rights and protect safe, legal access to medical cannabis.
It is important to stay active, engaged, and informed. Sign up to get ASA updates and learn more about ending patient discrimination.
Cannabis, in its natural form, is inherently safe for most patients, but it is especially susceptible to contaminants during cultivation, manufacturing, handling & even storing. Whether you are purchasing cannabis from regulated, grey, or illicit markets or cultivating your own cannabis, you should be aware of the contaminants commonly found in cannabis and the symptoms that accompany their presence.
Products sold in Wisconsin retail locations must be tested for contaminants, pesticides, and adulterants, in accordance with thresholds set by state regulators. Click here to see specific requirements for WI products.

For more information about cannabis safety, download ASA's "What’s in Your Cannabis? A Patient & Consumer Guide to Navigating Cannabis Safety."
Stigma and discrimination also make patients targets for law enforcement encounters. Keep in mind that the best law enforcement encounter is the one that never occurs! It's crucial for individuals involved in medical cannabis to understand not only medical cannabis laws and regulations but also their rights. Be Prepared. Learn about Your Rights!
Check out ASA's travel guide for patients and caregivers for tips on what to know before you go!
Get Involved! Learn more about ASA Campaigns and Take Action to improve the lives of medical cannabis patients today!
If you appreciate ASA's work, join now to become a part of the movement & sign up to get ASA updates
Navigating Wisconsin State Laws:
Patients and Caregivers: Enrolling and Accessing Medical Cannabis
Medical Professionals: Procedures for recommending Medical Cannabis
Policymakers and Advocates: Actions Needed to Improve Laws for Patients
Make Your Voice Heard! Take ASA's Patient & Consumer Survey
Your experiences and insights are crucial in shaping patient-centered medical cannabis policies. Take the Survey NOW!
For more information about cannabis safety, download ASA's "What’s in Your Cannabis? A Patient & Consumer Guide to Navigating Cannabis Safety."
Background on State Laws
CBD treatment is legal in Wisconsin. The program limits patients to cannabidiol preparations with 0.3 percent or less THC, in compliance with USDA hemp standards and authorizes in-state production according to those rules. Lydia’s Law (AB 726) was enacted in 2014, which created a legal right for access, possession and use for patients with seizure disorders. Since then, it has been revised to expand legal access. Details on how these laws apply to patients and medical professionals can be found below.
Here is a breakdown of how Wisconsin fared in ASA’s Annual State of the States Report, which evaluates the effectiveness of each state cannabis program from a patient perspective and assigns a grade using a rubric that reflects the key issues affecting patient access. Medical cannabis laws are constantly changing, ASA’s policy recommendations for Wisconsin can be found below. For policy updates Sign Up here or Take Action!
|
|
24/100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
0/100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
36/100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
50/100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
16/100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
0/200 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
15/100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Excerpted from ASA's 2022 State of the States Report. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share this page


